HuZAF Uses, Dosage, Side Effects and more
HuZAF (marketed under the trade name HuZAF™) is a humanized monoclonal antibody which is used as an immunosuppressive drug to treat Crohn's disease.
| Trade Name | HuZAF |
| Generic | Fontolizumab |
| Fontolizumab Other Names | Fontolizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in crohn's disease and psoriasis and psoriatic disorders.
How HuZAF works
HuZAF is a humanised antibody directed against recombinant human IFN-{gamma}. The antibody binds to natural human IFN-{gamma} and inhibits expression of IFN-{gamma} regulated genes known to be upregulated in Crohn’s disease.
